Dr. Roth stands as a distinguished figure in the realm of pediatric oncology, serving as the Director of Pediatric Oncology and an Associate Professor at Weill Cornell Medicine. Her expertise spans across the Departments of Pediatrics, Medicine, and Pathology and Laboratory Medicine, highlighting her comprehensive approach to cancer treatment. Previously, she was recognized as the Charles, Lillian and Betty Neuwirth Clinical Scholar in Pediatric Oncology from 2013 to 2019, a testament to her early career achievements. Patients also benefit from her dedicated care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, where she is an Associate Attending Pediatrician.
Academic Foundation and Medical Training of Doctor Roth
Doctor Roth’s journey in medicine began with her undergraduate studies at Duke University, setting a strong foundation for her future endeavors. She earned her medical degree from New York University School of Medicine, further solidifying her commitment to medical excellence. Her residency at NewYork-Presbyterian/Weill Cornell provided her with crucial experience, followed by a fellowship in pediatric hematology/oncology at the renowned Memorial Sloan-Kettering Cancer Center and NewYork-Presbyterian, where she also served as chief fellow, demonstrating her leadership and expertise in the field.
Specialization and Clinical Focus of Doctor Roth
Doctor Roth’s clinical practice is dedicated to the care of children, adolescents, and young adults facing diagnoses of lymphoma and leukemia. Her commitment to collaborative research and patient care is evident through her membership in the Children’s Oncology Group, where she actively participates in clinical trials for Hodgkin lymphoma and non-Hodgkin lymphoma. Further enhancing her collaborative approach, she is a vital member of the Weill Cornell Center for Lymphoma, an internationally acclaimed center recognized for its pioneering work in lymphoma treatment.
Doctor Roth’s Innovative Research in Lymphoma Treatment
Driven by a passion to advance treatment options, Doctor Roth’s research is centered on the discovery of innovative therapies for pediatric lymphoma. Her particular focus is on targeted therapies, which hold the promise of being less toxic than traditional chemotherapy and potentially effective for patients with chemotherapy-resistant disease. Her significant contributions to the field have been acknowledged through prestigious awards from esteemed institutions such as the National Institutes of Health (NIH), the Lymphoma Research Foundation, Hyundai Hope on Wheels Foundation, and the St. Baldrick’s Foundation, underscoring the impact of doctor roth’s work in pediatric oncology.
